Clinical Trial Update: Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and efficacy of Moroctocog alfa (AF-CC) in previously treated Hemophilia A patients has been completed. Results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Moroctocog alfa AF-CC (moroctocog alfa)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2016-12-21